Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

One interesting thing I have been pondering with NAVB at present is that the options that were recently issued to insiders are priced at 3.08. Since we had almost no run at all on apprroval except a brief visit to 3.59, I have to believe that our solid management team will now be working harder than ever to get the pps well above 4.00, 5.00, and 6.00, etc. DDbuyer is spot on when he says this management team consistently delivers and all things being equal, now that NAVB is under 3.00, the management team has all the motivation in the world to burn the shorts, not just for investors sake, BUT FOR THEMSELVES.

And with 4 products in their aresenal, plus royalties from the device sale, this game is jusssssssssst starting with the SHORTS creating their own DISADVANTAGE.

GLTA.